Literature DB >> 15994294

Transcription-dependent association of multiple positive transcription elongation factor units to a HEXIM multimer.

Cyprien Dulac1, Annemieke A Michels, Alessandro Fraldi, François Bonnet, Van Trung Nguyen, Giuliana Napolitano, Luigi Lania, Olivier Bensaude.   

Abstract

The positive transcription elongation factor (P-TEFb) comprises a kinase, CDK9, and a Cyclin T1 or T2. Its activity is inhibited by association with the HEXIM1 or HEXIM2 protein bound to 7SK small nuclear RNA. HEXIM1 and HEXIM2 were found to form stable homo- and hetero-oligomers. Using yeast two-hybrid and transfection assays, we have now shown that the C-terminal domains of HEXIM proteins directly interact with each other. Hydrodynamic parameters measured by glycerol gradient ultracentrifugation and gel-permeation chromatography demonstrate that both purified recombinant and cellular HEXIM1 proteins form highly anisotropic particles. Chemical cross-links suggest that HEXIM1 proteins form dimers. The multimeric nature of HEXIM1 is maintained in P-TEFb.HEXIM1.7SK RNA complexes. Multiple P-TEFb modules are found in the inactive P-TEFb.HEXIM1.7SK complexes. It is proposed that 7SK RNA binding to a HEXIM1 multimer promotes the simultaneous recruitment and hence inactivation of multiple P-TEFb units.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994294     DOI: 10.1074/jbc.M502471200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  The transcription-dependent dissociation of P-TEFb-HEXIM1-7SK RNA relies upon formation of hnRNP-7SK RNA complexes.

Authors:  Charlotte Barrandon; François Bonnet; Van Trung Nguyen; Valérie Labas; Olivier Bensaude
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

2.  Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb.

Authors:  Sonja A Dames; André Schönichen; Antje Schulte; Matjaz Barboric; B Matija Peterlin; Stephan Grzesiek; Matthias Geyer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

Review 3.  RNA polymerase II transcription elongation control.

Authors:  Jiannan Guo; David H Price
Journal:  Chem Rev       Date:  2013-08-06       Impact factor: 60.622

4.  Interplay between 7SK snRNA and oppositely charged regions in HEXIM1 direct the inhibition of P-TEFb.

Authors:  Matjaz Barboric; Jirí Kohoutek; Jason P Price; Dalibor Blazek; David H Price; B Matija Peterlin
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

5.  Tissue- and context-dependent modulation of hormonal sensitivity of glucocorticoid-responsive genes by hexamethylene bisacetamide-inducible protein 1.

Authors:  Noriaki Shimizu; Noritada Yoshikawa; Tadashi Wada; Hiroshi Handa; Motoaki Sano; Keiichi Fukuda; Makoto Suematsu; Takashi Sawai; Chikao Morimoto; Hirotoshi Tanaka
Journal:  Mol Endocrinol       Date:  2008-09-18

6.  An evolutionary conserved Hexim1 peptide binds to the Cdk9 catalytic site to inhibit P-TEFb.

Authors:  Lydia Kobbi; Emmanuelle Demey-Thomas; Floriane Braye; Florence Proux; Olga Kolesnikova; Joelle Vinh; Arnaud Poterszman; Olivier Bensaude
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-25       Impact factor: 11.205

Review 7.  CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation.

Authors:  Sungyoo Cho; Sebastian Schroeder; Melanie Ott
Journal:  Cell Cycle       Date:  2010-05-29       Impact factor: 4.534

Review 8.  Hexim1, an RNA-controlled protein hub.

Authors:  Annemieke A Michels; Olivier Bensaude
Journal:  Transcription       Date:  2018-02-23

9.  Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat.

Authors:  Lisa Muniz; Sylvain Egloff; Bettina Ughy; Beáta E Jády; Tamás Kiss
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

10.  Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells.

Authors:  Sungyoo Cho; Sebastian Schroeder; Katrin Kaehlcke; Hye-Sook Kwon; Angelika Pedal; Eva Herker; Martina Schnoelzer; Melanie Ott
Journal:  EMBO J       Date:  2009-04-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.